Drug Repurposing Trends - A CDMO Perspectives

In this interactive webinar, Dr. Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, reviews drug repurposing trends and covers the following topics:

• Drug Repurposing
  • History
  • Advantages & Disadvantages
  • Global Trends
• Approaches Used To Increase Success Rates
• Potential Drug Repurposing Pathways
• Drug Repurposing-- Business Opportunities
• Off-Label Use Of Approved Drugs
• CDMO Role In Supporting Drug Repurposing To Approval
• Summary & Conclusions

Dr. Kane shares some case studies to demonstrate how a CDMO plays a role in drug repurposing and supporting the pharmaceutical industry in taking drugs to market approval.

There is also a brief question and answer session.